药物经济学和功效研讨专家批评 SCIESSCI

期刊简介估计审稿时候： 较慢,6-12周

Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review.

The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.

《药物经济学与功效研讨专家批评》（ISSN 1473-7167）供给与药物临床利用和医治体例相干的本钱效益和药物经济学题目的专家批评。内容包含药物经济学和糊口品质研讨、医治功效、循证医学和本钱效益研讨。一切文章均颠末严酷的同业评审。

该期刊接纳怪异的专家批评文章格局，周全概述关头手艺范畴、研讨或临床理论确当前思惟，并辅以以下局部：

专家定见 - 对文章中显现的数据的小我概念、对将来可以或许主要的成长的会商和跟着进一步研讨发生更具体的功效而可以或许变得使人高兴的研讨路子

文章重点 - 作者最关头概念的履行择要。

《Expert Review Of Pharmacoeconomics & Outcomes Research》(药物经济学和功效研讨专家批评)编辑部通信体例为2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。